Purdue Pharma

Following the US Supreme Court's ruling rejecting the Purdue Pharma bankruptcy plan's nonconsensual third-party releases, legal observers say bankruptcy courts may see more attempts to use Subchapter V of the small-business reorganization rules to impose nondebtor stays and achieve similar protections for third parties. Attorneys are weighing whether the workaround can survive challenges, with implications for mass-tort and opioid-related litigation strategy.